Diabetes attenuates the antidepressant-like effect mediated by the activation of 5-HT1A receptor in the mouse tail suspension test.
about
Diabetes-associated depression: the serotonergic system as a novel multifunctional targetOn the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039.Eating high fat chow increases the sensitivity of rats to 8-OH-DPAT-induced lower lip retraction.Depressive phenotypes evoked by experimental diabetes are reversed by insulinFood restriction and streptozotocin treatment decrease 5-HT1A and 5-HT2A receptor-mediated behavioral effects in rats.High-fat diet-induced metabolic disorders impairs 5-HT function and anxiety-like behavior in miceFood restriction and streptozotocin differentially modify sensitivity to the hypothermic effects of direct- and indirect-acting serotonin receptor agonists in rats.Restricted access to standard or high fat chow alters sensitivity of rats to the 5-HT(2A/2C) receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.5-HT1A receptor-regulated signal transduction pathways in brain.Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.Streptozotocin-induced insulin deficiency leads to development of behavioral deficits in rats.Stress symptoms induced by repeated morphine withdrawal in comparison to other chronic stress models in mice.The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent.Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: reversion by antidepressant treatment.Diabetes modulates ethanol-induced increase in serotonin release from rat hippocampus: an in vivo microdialysis study.
P2860
Q26864574-55E1D2E6-D393-4343-85E4-2A5EC39222AAQ34130874-11C04DCC-3991-4A46-B5CE-620CB03965F9Q35539746-D520BD8D-1683-4ADF-9C84-CA7FEEC30A75Q35613538-51285217-7BA9-423D-9E97-A4DC7EF8474CQ36297068-120C2F24-97AF-4B87-A493-454EEE3F1074Q37005127-5FCA1543-7438-4E5E-A9B8-547B3188C631Q37328323-865A9A0A-AF39-48AF-B820-4B0BBC6B1ED2Q37619179-6E66A991-6F95-4982-B2C7-E0D00A95D00BQ37723815-22A9287A-4B86-41B6-83B4-A578E7FD26BCQ38075505-F4776546-B947-409A-B702-4898C2428D28Q44834034-8B9B471B-52EE-4352-98B8-FDEE709E02D1Q46601839-CBF52A5F-8D4F-4C51-8975-547AF84A92BAQ47745303-1002AB24-DEA4-4699-82BB-58B3D5C97150Q48609170-10E40B22-5DA5-4B6E-B89A-1DC35430490FQ49049845-3570697B-632F-4D44-9687-CFFF7EF2A984
P2860
Diabetes attenuates the antidepressant-like effect mediated by the activation of 5-HT1A receptor in the mouse tail suspension test.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Diabetes attenuates the antide ...... he mouse tail suspension test.
@en
Diabetes attenuates the antide ...... he mouse tail suspension test.
@nl
type
label
Diabetes attenuates the antide ...... he mouse tail suspension test.
@en
Diabetes attenuates the antide ...... he mouse tail suspension test.
@nl
prefLabel
Diabetes attenuates the antide ...... he mouse tail suspension test.
@en
Diabetes attenuates the antide ...... he mouse tail suspension test.
@nl
P2093
P2860
P356
P1476
Diabetes attenuates the antide ...... he mouse tail suspension test.
@en
P2093
Junzo Kamei
Shigeo Miyata
Shoko Hirano
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300354
P407
P577
2004-03-01T00:00:00Z